Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.
Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have increased year by year. HCC research has increasingly focused on ...
A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.
1d
GlobalData on MSNFDA grants fast track status to Rznomics’ RZ-001 for HCCThe US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of ...
7d
Vietnam Investment Review on MSNLion TCR s Liocyx M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV Related Hepatocellular CarcinomaOn 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...
Dr. Waqqas Tai is a cancer doctor who often shares health advice online. He recently revealed what the five most "lethal" ...
As reported in Biophotonics Discovery, the team developed a novel microscopy technique that ... focused on head and neck squamous cell carcinoma (HNSCC), a type of cancer that is often resistant ...
As reported in Biophotonics Discovery, the team developed a novel microscopy technique that ... in radioresistant head and neck squamous carcinoma cells, Biophotonics Discovery (2025).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results